Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 9/20 | 0.59 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.56 |
| ▸ | RRM1 | P23921 | 1/20 | 0.56 |
| ▸ | CASP2 | P42575 | 1/20 | 0.53 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.53 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.53 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.53 |
| ▸ | MMP8 | P22894 | 1/20 | 0.53 |
| ▸ | FNTA | P49354 | 1/20 | 0.53 |
| ▸ | FNTB | P49356 | 1/20 | 0.53 |
| ▸ | NAAA | Q02083 | 3/20 | 0.51 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28510027 | 0.86 | EPHX1 (0.57) | EPHX1DPP7RRM1CASP2GNAI3 | |
| SCHEMBL26087872 | 0.86 | EPHX1 (0.57) | EPHX1DPP7RRM1CASP2GNAI3 | |
| SCHEMBL11704311 | 0.86 | EPHX1 (0.57) | EPHX1DPP7RRM1CASP2GNAI3 | |
| SCHEMBL9615265 | 0.82 | DPP7 (0.65) | EPHX1DPP7RRM1CASP2GNAI3 | |
| SCHEMBL24072564 | 0.81 | EPHX1 (0.61) | EPHX1DPP7RRM1CASP2GNAI3 | |
| SCHEMBL14076747 | 0.81 | EPHX1 (0.61) | EPHX1DPP7RRM1CASP2GNAI3 | |
| SCHEMBL25454649 | 0.81 | EPHX1 (0.61) | EPHX1DPP7RRM1CASP2GNAI3 | |
| SCHEMBL10248180 | 0.81 | EPHX1 (0.61) | EPHX1DPP7RRM1CASP2GNAI3 | |
| SCHEMBL4333323 | 0.81 | EPHX1 (0.61) | EPHX1DPP7RRM1CASP2GNAI3 | |
| SCHEMBL7769538 | 0.81 | EPHX1 (0.61) | EPHX1DPP7RRM1CASP2GNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE44510-E1 | Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof | SONY DEUTSCHLAND GMBH (DE) | 2013-09-24 | — | — | US | disclosed |
| US-8173842-B2 | Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof | SONY DEUTSCHLAND GMBH (DE) | 2012-05-08 | — | — | US | disclosed |
| US-7923576-B2 | Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof | SONY DEUTSCHLAND GMBH (DE) | 2011-04-12 | — | — | US | disclosed |
| EP-1215205-B1 | Tuned multifunctional linker molecules for electronic charge transport through organic-inorganic composite structures and use thereof | SONY DEUTSCHLAND GMBH (DE) | 2007-11-21 | — | — | EP | disclosed |
| US-20060138408-A1 | Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof | SONY DEUTSCHLAND GMBH (DE) | 2006-06-29 | — | — | US | disclosed |
| US-20060113530-A1 | Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof | SONY DEUTSCHLAND GMBH (DE) | 2006-06-01 | — | — | US | disclosed |
| US-7030271-B2 | Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof | SONY INTERNATIONAL (EUROPE) GMBH (DE) | 2006-04-18 | — | — | US | disclosed |
| US-20020127756-A1 | Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof | SONY DEUTSCHLAND GMBH (DE) | 2002-09-12 | — | — | US | disclosed |
| EP-1215205-A1 | Tuned multifunctional linker molecules for electronic charge transport through organic-inorganic composite structures and use thereof | Sony International (Europe) GmbH (DE) | 2002-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060138408-A1 | Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof | CORO1C, EXOC1, CLINT1 | EPHX1 3604/4885DPP7 4768/4885RRM1 2554/4885 |
| US-20060113530-A1 | Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof | CORO1C, CALCOCO2, KCNC1 | EPHX1 3653/4885DPP7 4769/4885RRM1 2626/4885 |
| US-20020127756-A1 | Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof | CORO1C, CACNG2, KCNC1 | EPHX1 3868/4885DPP7 4666/4885RRM1 3316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.